Tyisha Howe

Aflibercept for ROP Shows Sustained Efficacy at Age 3

Aflibercept for ROP Shows Sustained Efficacy at Age 3

October 2, 2024

TOPLINE: A src.4 mg dose of aflibercept in infancy to treat retinopathy of prematurity (ROP) shows sustained efficacy and safety at...

FluoGuide submits clinical trial application for head and neck cancer treatment

October 7, 2024

Scottish patients first in UK to access new lung cancer treatment

October 7, 2024

‘Physician Spending Is Not the Problem in Healthcare’: What We Heard This Week

‘Physician Spending Is Not the Problem in Healthcare’: What We Heard This Week

October 6, 2024

Machine learning model can diagnose Meniere disease

Machine learning model can diagnose Meniere disease

October 6, 2024

Rwanda will deploy Marburg vaccine under trial as death toll rises to 12

Rwanda will deploy Marburg vaccine under trial as death toll rises to 12

October 6, 2024